SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Sick Visit — Rachel Carson

PatientRachel Carson
Date of birth1973-05-27
IdentifiersMRN HR-ML041-SYN; SSN (made up) 000-41-5068
Document date2026-07-20
AuthorMargaret Vance-Okonkwo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Blocked nose, facial pressure, and cough for five days. [S]

History of Present Illness

Ms. Carson is a 53-year-old woman with stage IIB hormone receptor-positive left breast cancer, five weeks into letrozole and on day 8 of her second 28-day cycle of ribociclib. Five days ago she developed a blocked nose, clear then yellow discharge, pressure over both cheeks, a sore throat, and a dry cough. She has had no fever on her home thermometer, checked twice a day as the oncology team taught her, and no chills, breathlessness, or chest pain. The symptoms are no worse than three days ago. She has used saline spray. She called the oncology nurse line, who asked her to be seen today with a blood count. She wanted to know whether this was dangerous on ribociclib and whether she should stop it, and asked for a plain answer. [S]

ElementDetail
OnsetFive days ago
LocationNose, both cheeks, throat
DurationFive days, not worsening
CharacterCongestion, colored discharge, facial pressure, dry cough
SeverityMild to moderate; writing most mornings
ContextDay 8 of ribociclib cycle 2; letrozole daily
Modifying factorsSaline spray helps a little
Associated signs and symptomsNo fever, breathlessness, chest pain, or ear pain

Review of Systems

SystemResultFinding
ConstitutionalPositiveTired; no fever or chills
Ears, nose, mouth, and throatPositiveBlocked nose, colored discharge, cheek pressure, sore throat
RespiratoryPositiveDry cough; no breathlessness or wheeze
CardiovascularNegativeNo palpitations, fainting, or chest pain
GastrointestinalNegativeNo diarrhea, mouth sores, or abdominal pain
IntegumentaryNegativeNo rash; radiation skin healed

6 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Omeprazole 20 mg delayed-release oral capsule, one capsule by mouth once daily before breakfast, to complete eight weeks of ulcer healingOne capsule once daily before breakfastOral route2026-01-19 to 2026-04-03completedS
Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for knee pain, no more than 3000 mg a dayTwo tablets up to every 8 hours as neededOral route2025-06-02activeS
Letrozole 2.5 mg oral tablet, one tablet by mouth once daily, planned for at least five yearsOne tablet once dailyOral route2026-06-15activeS
Ribociclib 200 mg oral tablet, two tablets (400 mg) by mouth once daily on days 1 to 21 of each 28-day cycle, with letrozole, planned for three yearsTwo tablets once daily on days 1 to 21 of each 28-day cycleOral route2026-06-15activeS
Zoledronic acid 4 mg in 100 mL intravenous infusion over 15 minutes every six months for three yearsOne infusion every six monthsIntravenous route2026-06-15activeS
Cholecalciferol (vitamin D3) 1000 units oral tablet, one tablet by mouth once dailyOne tablet once dailyOral route2026-06-15activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-07-20Body height163cmS
2026-07-20Body weight59.2kgS
2026-07-20Body mass index (BMI) [Ratio]22.3kg/m2S
2026-07-20Systolic blood pressure118mm[Hg]S
2026-07-20Diastolic blood pressure74mm[Hg]S
2026-07-20Heart rate82/minS
2026-07-20Respiratory rate16/minS
2026-07-20Body temperature37.3CelS
2026-07-20Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-07-20Leukocytes [#/volume] in Blood by Automated count2.910*3/uL4-11 10*3/uLLowS
2026-07-20Neutrophils [#/volume] in Blood by Automated count1.210*3/uL1.8-7.7 10*3/uLLowS
2026-07-20Hemoglobin [Mass/volume] in Blood12.2g/dL12-15.5 g/dLNormalS
2026-07-20Platelets [#/volume] in Blood by Automated count16810*3/uL150-400 10*3/uLNormalS

Physical Exam

Vital signs recorded on 2026-07-20; see the Vital Signs section. [S]

SystemFinding
GeneralTired but well-appearing; temperature 37.3 °C
Ears, nose, and throatSwollen nasal lining with mucopurulent discharge; mild tenderness over both maxillary sinuses; throat mildly red without exudate; ear drums normal; no mouth ulcers
NeckSmall tender anterior cervical nodes; no supraclavicular nodes
RespiratoryClear on both sides; oxygen saturation 98 percent
CardiovascularRegular rhythm, 82/min

Problems

ProblemClinical statusVerificationCodeProvenance
Invasive ductal carcinoma of the left breast, upper outer quadrant at 2 o'clock, 2.4 cm on imaging; core biopsy grade 2, estrogen and progesterone receptor positive, HER2 negative, Ki-67 22 percent; clinical stage T2 N0 (cT2 cN0 M0); synthetic modern counterpart of the documented 1960 breast cancer, which was not disclosed to heractiveconfirmed C50.412S — Synthetic tumor details, stage, and treatment; the breast lumps, the 1960 operation, and the nondisclosure are documented (D), but no tumor details from her lifetime are used.
Estrogen receptor positive status of the breast cancer (ER 95 percent, PR 80 percent)activeconfirmed Z17.0S — Synthetic receptor result; no receptor status from her lifetime is known.
New firm lump in the upper outer quadrant of the left breast, found two weeks ago; clinically suspicious; diagnostic imaging and biopsy bookedresolvedconfirmed N63.21S — Synthetic presenting concern at the index visit, superseded by the biopsy diagnosis; the lumps in the left breast in early 1960 are documented (D).
Duodenal ulcer found at endoscopy seven weeks ago, with Helicobacter pylori on biopsy; treated with 14 days of bismuth quadruple therapy and completing eight weeks of omeprazole; test of cure plannedresolvedconfirmed K26.9S — Synthetic modern ulcer; it echoes the ulcer among her documented illnesses, which the sources do not date.
Primary osteoarthritis of both knees, mild, with stiffness after long walks on the shoreactiveconfirmed M17.0S — Synthetic condition; it is not linked to the documented word arthritis, which she may have used to keep her cancer private.
Metastatic carcinoma in two of three left axillary sentinel lymph nodes (macrometastases, no extranodal extension); pathologic stage pT2 pN1a(sn) M0, anatomic stage IIB; recurrence score 17activeconfirmed C77.3S — Synthetic surgical pathology; spread to lymph nodes is documented later in her life, but no pathology from her lifetime is used.
Long-term use of letrozole as adjuvant endocrine therapy, with ribociclib for three yearsactiveconfirmed Z79.811S — Synthetic treatment status.
Low bone mass (osteopenia) on baseline DXA before letrozole: lumbar spine T-score -1.8, femoral neck -1.3; 10-year major osteoporotic fracture risk about 7 percent (FRAX); vitamin D insufficiencyactiveconfirmed M85.80S — Synthetic finding on the baseline DXA the protocol requires for an aromatase inhibitor.
Acute viral rhinosinusitis for five days while on ribociclib, with expected grade 2 neutropenia (absolute neutrophil count 1.2) and no fever; resolved with saline irrigationresolvedconfirmed J01.90S — Synthetic common illness; it echoes the sinus infection among her documented illnesses, which the sources do not date, and is not linked to that claim.

Assessment and Plan

Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 5.2025 (2025); KISQALI (ribociclib) tablets: prescribing information (dosage for early breast cancer; QT, hepatotoxicity, and neutropenia monitoring) (2026); IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults. Clin Infect Dis 2012;54(8):e72-e112 (2012)

Follow-up: Telephone check in three days. Return if symptoms pass ten days or worsen. Oncology blood count at the start of the next cycle. Next scheduled visit 2026-09-08: monitoring visit at the start of the fourth ribociclib cycle. [S]